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Introduction
Among more than 120 types of brain tumor, glioblastoma multiforme (GBM) is the most aggressive and lethal form due to its rapid growth rate, high invasiveness to surrounding normal tissues, and ability to escape the host immune system (Kelly et al., 1984; Furnari et al., 1995; Kleihues et al., 1995; Prados, 2000; Holland, 2001) . Although several therapeutic approaches have been applied, including surgery, radiotherapy, and chemotherapy, none of these treatments is very effective at halting tumor progression (Marks, 1989; Hosli et al., 1998; Mangiola et al., 2010; Nicholas et al., 2011) . Of interest, a large proportion of microglia/macrophages cells are found within this type of malignant human glioma as well as mouse models of the disease (Graeber et al., 2002; Liu et al., 2009; Charles et al., 2011) . Generally, these myeloidderived, macrophage-like microglial cells function as the main form of immune defense in the central nervous system (Gehrmann et al., 1995; Alliot et al., 1999; Streit, 2001; Chan et al., 2007; Rivest, 2009) . When activated by pathological changes in the brain, they transform from a resting state to a pro-inflammatory phenotype that is capable of phagocytosis, cytotoxicity, and antigen presentation through the high expression of major histocompatibility complex (MHC) class II molecules (Gehrmann et al., 1995; Davalos et al., 2005; Fetler and Amigorena, 2005; Nimmerjahn et al., 2005; Stoll et al., 2006) . Opposite to their normal function in the immune system, glioma infiltrated microglia/macrophages show an anti-inflammatory phenotype, in which the expression of MHC class II molecules is down-regulated, especially in brain tumors with high malignancy (Morantz et al., 1979; Roggendorf et al., 1996; Tran et al., 1998; Flügel et al., 1999; Badie and Schartner, 2001; Badie et al., 2002; Bettinger et al., 2002; Watters et al., 2005) , possibly by glioma-secreted factors, including IL-4, IL-6, IL-10, transforming growth factor β (TGFβ), and prostaglandin E2, (Charles et al., 2011) . A positive correlation between the number of infiltrating microglia/macrophages and the proliferation rate of the tumor is also evident (Morimura et al., 1990; Graeber et al., 2002) . Thus, these immune cells are believed to contribute to the local immunosuppressive milieu of glioma, as well as promote tumor progression (Markovic et al., 2005; Hussain et al., 2006; Yang et al., 2010) . Despite the potential importance of microglia/macrophages in glioma tumorigenesis, the mechanism by which microglia/macrophages infiltrate into the tumor is still unknown. Increasing evidence supports the hypothesis that glioma regulates this mechanism through different factors, including hepatocyte growth factor/scatter factor (HGF/SF), colony-stimulating factor 1 (CSF-1), granulocyte-colony stimulatory factor (G-CSF) (Nitta et al., 1992; Alterman and Standley, 1994; Badie et al., 1999) , or possibly MMP-2 and MMP-9, which are found abundantly within glioma (Nakada et al., 2003) . Current studies strongly suggest that this localization may require the presence of chemokines, a family of chemoattractant cytokines, in the tumor microenvironment (Leung et al., 1997; Kielian et al., 2002; Platten et al., 2003; Sciumè et al., 2010) .
Due to their chemoattractant property, chemokines and chemokine receptors are well-known for guiding the migration of cells (Allen et al., 2007) . During tumorigenesis, chemokine networks play important roles in many processes required for tumor development,
